Anlotinib improved the reactive cutaneous capillary endothelial proliferation induced by camrelizumab: a case report

BACKGROUND: Programmed cell death protein-1 (PD-1) or its ligand PD-L1 monoclonal antibodies, opening a new era of tumor immunotherapy, and they have significantly improved the overall survival of many patients with advanced solid tumors. However, in addition to its effectiveness, we should also pay...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Rui, Ju, Yinghui, Long, Tengfei, Su, Zhuping, Zhu, Gaochao, Liu, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459630/
https://www.ncbi.nlm.nih.gov/pubmed/36093549
http://dx.doi.org/10.21037/tcr-22-426